Stay updated on Cabozantinib for Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T20:10:04.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Footer revision indicator updated from v3.4.1 to v3.4.2; no other content or study details appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:39:54.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision indicator updated in the page footer from v3.4.0 to v3.4.1. There are no observed changes to the study's content or site navigation.
    Difference
    0.1%
    Check dated 2026-02-04T23:00:37.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Show glossary toggle has been added to the page. QC-related and version metadata have been updated to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the prior labels and text such as 'Last Update Submitted that met QC Criteria' and 'Revision: v3.3.4', with capitalization adjustments for 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T19:15:36.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4. This appears to be a minor metadata/version update.
    Difference
    0.1%
    Check dated 2026-01-14T03:52:25.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Locations section now lists Massachusetts as a study site. The older Massachusetts Locations entry and the HHS Vulnerability Disclosure were removed, and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:05:46.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.